Raymond T Chung Selected Research

DNA-like RNA (D-RNA)

2/2022

One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond T Chung Research Topics

Disease

127	Infections 06/2022 - 06/2002
103	Fibrosis (Cirrhosis) 05/2022 - 05/2005
63	Hepatitis C 02/2022 - 12/2003
47	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2003
39	Non-alcoholic Fatty Liver Disease 01/2022 - 06/2012
38	Liver Diseases (Liver Disease) 10/2022 - 05/2005
30	Chronic Hepatitis C 10/2019 - 07/2002
24	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2002
23	Inflammation (Inflammations) 01/2022 - 05/2005
21	HIV Infections (HIV Infection) 12/2021 - 05/2006
20	Hepatitis B 10/2022 - 03/2004
20	Neoplasms (Cancer) 01/2021 - 11/2003
19	Coinfection 10/2022 - 09/2002
13	Virus Diseases (Viral Diseases) 04/2021 - 12/2002
12	End Stage Liver Disease 01/2021 - 06/2007
11	Insulin Resistance 01/2022 - 12/2003
10	Fatty Liver 10/2022 - 01/2013
10	Chronic Hepatitis B 01/2022 - 03/2004
10	Viremia 01/2022 - 12/2002
10	Obesity 01/2022 - 08/2009
8	Hepatitis 01/2022 - 05/2010
8	COVID-19 01/2022 - 01/2020
8	Persistent Infection 01/2021 - 07/2005
7	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 10/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2014
6	Hypertension (High Blood Pressure) 11/2021 - 05/2009
5	Necrosis 11/2021 - 11/2012
5	Acute Kidney Injury (Acute Renal Failure) 11/2021 - 07/2015
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 09/2002
4	Hepatic Encephalopathy 01/2022 - 01/2020
4	Carcinogenesis 01/2022 - 01/2013
4	Hemorrhage 12/2020 - 12/2007
4	Proteinuria 08/2020 - 02/2016
4	Chronic Renal Insufficiency 08/2020 - 01/2016
4	Glomerulonephritis 01/2018 - 12/2002
4	Disease Progression 01/2014 - 08/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
3	Hepatorenal Syndrome 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

78	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2003
49	InterferonsIBA 01/2022 - 07/2002
32	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 12/2002
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
26	RNA (Ribonucleic Acid)IBA 10/2022 - 09/2002
23	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
14	CytokinesIBA 03/2021 - 02/2005
13	Alanine Transaminase (SGPT)IBA 11/2021 - 12/2003
12	SofosbuvirIBA 08/2020 - 01/2015
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2022 - 09/2012
10	AntigensIBA 06/2022 - 09/2004
10	Pharmaceutical PreparationsIBA 01/2022 - 05/2010
9	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 10/2008
9	Hepatitis B e AntigensIBA 01/2022 - 11/2015
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2015
8	LipidsIBA 10/2022 - 10/2009
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2006
8	Interferon-alpha (Interferon Alfa)IBA 01/2019 - 08/2004
7	CreatinineIBA 08/2020 - 11/2012
6	VaccinesIBA 06/2022 - 12/2002
6	LigandsIBA 01/2022 - 05/2008
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 04/2016
6	EpitopesIBA 01/2019 - 06/2002
5	EnzymesIBA 01/2022 - 02/2005
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2011
5	Peptides (Polypeptides)IBA 01/2022 - 09/2004
5	Interferon LambdaIBA 03/2021 - 04/2014
5	tesamorelin FDA Link 01/2021 - 12/2019
5	CholesterolIBA 01/2021 - 10/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2007
5	telaprevirIBA 01/2018 - 09/2010
5	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2013
5	BilirubinIBA 08/2015 - 05/2006
4	Tenofovir (Viread)FDA Link 05/2022 - 03/2004
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2020
4	Transaminases (Aminotransferases)IBA 01/2022 - 11/2006
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022 - 01/2013
4	CollagenIBA 01/2022 - 12/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2018
4	nasIBA 01/2021 - 08/2015
4	IronIBA 01/2020 - 11/2006
4	sofosbuvir drug combination ledipasvirIBA 01/2019 - 01/2016
4	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2018 - 09/2010
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 09/2010
4	Small Interfering RNA (siRNA)IBA 11/2016 - 06/2010
4	Epidermal Growth Factor (EGF)IBA 04/2016 - 01/2008
4	Rituximab (Mabthera)FDA Link 12/2015 - 05/2006
4	Interferon alpha-2 (Roferon-A)FDA Link 12/2010 - 12/2002
3	Lipoproteins (Lipoprotein)IBA 10/2022 - 06/2014
3	glecaprevir and pibrentasvirIBA 02/2022 - 10/2019
3	AngiotensinsIBA 01/2022 - 05/2009
3	Amino Acids FDA Link 01/2022 - 06/2007

Therapy/Procedure

96	Therapeutics 05/2022 - 07/2002
37	Liver Transplantation 01/2022 - 02/2002
8	Transplantation 04/2020 - 07/2013
7	Kidney Transplantation 02/2022 - 02/2002
4	Bariatric Surgery 01/2022 - 01/2013
4	Chemoprevention 01/2022 - 11/2014
4	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 09/2002
4	Palliative Care (Palliative Therapy) 01/2021 - 01/2019
4	Drug Therapy (Chemotherapy) 01/2019 - 03/2011